Table 6.
The expression levels of miR-16-5p and miR-19b-3p in the supplementary phase I.
| aveΔCt | Sd | 2-ave△△Ct | P value | |
|---|---|---|---|---|
| h16c39 | ||||
| N | 6.975 | 1.301 | 1.826 | 0.011 |
| Prec | 7.844 | 1.513 | 1 | |
| T1 | 7.811 | 1.062 | 1.023 | 0.891 |
| T2-4 | 8.389 | 1.016 | 0.685 | 0.039 |
| h19bc39 | ||||
| N | 11.530 | 1.570 | 1.619 | 0.029 |
| Prec | 12.225 | 1.410 | 1 | |
| T1 | 12.265 | 1.415 | 0.973 | 0.891 |
| T2-4 | 13.256 | 1.505 | 0.489 | 0.002 |
| h19bavec39h16 | ||||
| N | 8.042 | 0.983 | 1.198 | 0.098 |
| Prec | 8.303 | 1.095 | 1 | |
| T1 | 8.525 | 0.872 | 0.857 | 0.752 |
| T2-4 | 9.110 | 1.271 | 0.572 | 0.002 |
2-ave△△Ct, the ratio of the average expression level of the miRNA for the special cohort to that for the Prec cohort. aveΔCt and Sd, as stated in Table 3; h16c39, h19bc39 and h19bavec39h16, as stated in Fig. 3. Mann-Whitney U test was used to determine statistical significance at the level of P<0.05.